04-Aug-2020 | Zion Market Research
Zion Market Research (www.zionmarketresearch.com) has published a new report titled “COVID-19 Sample Collection Kits Market by Product(Swabs, Viral Transport Media, Blood Collection Kits, and Other Consumables); by Application (Diagnostics, and Research); By Site of Collection (Hospitals & Clinics, Home Test): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026”. According to the report, global demand for COVID-19 Sample Collection Kits market was valued at approximately USD 2.1 billion in 2020, and is expected to generate revenue of around USD 2.9 billion by end of 2026, growing at a CAGR of around 4.5% between 2020 and 2026.
Browse the full “COVID-19 Sample Collection Kits Market by Product (Swabs, Viral Transport Media, Blood Collection Kits, Other Consumables), by Application (Diagnostics, Research), and Site of Collection (Hospitals & Clinics, Home Test) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026.” Report at https://www.zionmarketresearch.com/report/covid-19-sample-collection-kits-market
Sample collection is the most important step in the diagnosis of many infectious diseases which include infections with coronavirus also. Inappropriate and imprecise selection of samples can result in false or negative test results. The Centers for Disease Control and Prevention ( CDC) has therefore permitted a standard protocol for collecting and transporting specimens with respect to the SARS-CoV-2 testing. Such regulatory guidelines have offered to help streamline the use of the sample collection kits COVID-19. While COVID-19 diagnostic testing proceeds to expand, multiple studies are conducted to examine diverse methods to taking samples which provide reliable data. A study found that saliva samples obtained from patients with the infection have greater sensitivity and accuracy to identification than the previously used approach to nasopharyngeal disease. It was also found that tests collected using saliva samples demonstrated low inconsistency, which is expected to rise this this method in the future. The United States Food and Drug Administration approved the first diagnostic test kit with a COVID-19 home collection method due to emergence of covid 19.
The increase in COVID-19 situation , and the availability of insufficient laboratory-based molecular testing ability would serve as an important drivers in the growth of the global market for COVID-19 Sample Collection Kits. Technological advancements, An increase in antibody identification, increased government support, and increasing use of COVID-19 Sample Collection Kits in emerging markets will act as an opportunity for the market players in the COVID-19 Sample Collection Kits market. Nonetheless, Lack of test-related materials, such as reverse transcription-polymerase chain reaction devices, swabs and COVID-19 virus control samples, and shortage of laboratory reagents will restrict the growth of global COVID-19 Sample Collection Kits market.
The global COVID-19 Sample Collection Kits market has been split into Product, Application, Site of Collection, and region. Based on Product, Global COVID-19 Sample Collection Kits Market is segmented into Swabs, Viral Transport Media, Blood Collection Kits, and Other Consumables. Based on Application, market is segmented into Diagnostics, and Research. The Site of Collection segment of the COVID-19 Sample Collection Kits Market is categorized into Hospitals & Clinics, and Home Test.
Region wise, the COVID-19 Sample Collection Kits market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America will be the leading region during the forecast period. Increasing cases of covid-19,Large patients of covid 19, presence of major manufacturers of COVID-19 Sample Collection Kits in this region, will boost the market growth in this region. Europe will be the second largest market. The major reasons are High amount of swabs in the region checked, and high impact of pandemics like COVID-19. Asia Pacific will thrive at lucrative rate over the forecast period due to high incidences of Covid 19 outbreak, and because of efforts by home-grown firms to enlarge their services. Latin America market will grow at a prominent rate during the estimate period. The Middle Eastern and African countries are expected to experience rich growth in the predictable time.
The report also includes detailed profiles of key players such Everlywell, EKF Diagnostics, Thermo Fisher Scientific, Inc., Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Lucence Diagnostics Pte Ltd., Hardy Diagnostics, Mylab Discovery Solutions, BNTX Inc., Formlabs, Medline Industries, Inc., HiMedia Laboratories, VIRCELL S.L among others.
The report segment of global COVID-19 Sample Collection Kits market as follows:
Global COVID-19 Sample Collection Kits Market: By Product
Global COVID-19 Sample Collection Kits Market: By Application
Global COVID-19 Sample Collection Kits Market: By Site of Collection
Global COVID-19 Sample Collection Kits Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651